Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment

These results support longer trials of intranasal insulin therapy for patients with amnestic mild cognitive impairment and patients with AD. Trial Registration clinicaltrials.gov Identifier: NCT00438568.